Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) — Cyborg Score 7/10

Strong
Generic and biosimilar pharmaceuticals

Strategic Profile

SPIMACO is positioned as Saudi Arabia's leading generics and biosimilar pharmaceutical manufacturer, commanding a robust 7.4% private sector market share and holding a prominent position in the Middle East. The company has accelerated efforts towards realizing its strategic ambition of becoming the national champion for the Kingdom's pharmaceutical industry and the leading pharmaceutical company in the MENA region, leveraging favorable market dynamics and a growing aging patient base.

Cyborg Score Rationale

SPIMACO commands market leadership in Saudi Arabia's private pharma sector with substantial manufacturing scale (2.3B+ units annually), diversified product portfolio (400+ SKUs), and meaningful regional footprint (21 markets across MENA). However, exposure to price-regulated markets and generic/biosimilar focus limits margin upside relative to specialty-pharma peers.

Top Insights

  • SPIMACO holds a 7.4% private sector market share as Saudi Arabia's leading generics and biosimilar pharmaceutical manufacturer
  • The company operates 7 state-of-the-art manufacturing facilities across 4 countries with production capacity exceeding 2.3 billion units annually
  • Saudi Arabia's pharmaceutical market is projected to grow by 8-9% annually between now and 2027
  • SPIMACO was established in 1986 as a Saudi Joint-Stock company with fully paid-up capital of SR 1.2 billion

Named Competitors

  • Hikma Pharmaceuticals — Middle East and North Africa regional pharmaceutical manufacturer
  • Tabuk Pharmaceuticals — Saudi Arabian generic pharmaceutical manufacturer competing in MENA region
  • Riyadh Pharma — Saudi generic pharmaceutical manufacturer with manufacturing facilities for domestic and international markets

Recent Developments

  • (2023) SPIMACO announced FY23 results, maintaining leadership position in Saudi private sector pharma industry
  • (2024) Company signed collaborative agreements with Saudi Arabia's Local Content and Government Procurement Authority for healthcare sector initiatives

Open the full interactive Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →